DRL

Location

Vlaams Brabant

Founded

1980-09-05

Risk Signals

105 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Furniture, Catalog and Mail-Order Houses), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about DRL

Live alerts from global media, monitored by Business Radar

Dr. Reddy's and Novartis sign agreement for anti-diabetes products

2024-05-27 (pharmaceutical-technology.com)

Dr. Reddy's and Novartis sign agreement for anti-diabetes products

Dr. Reddy's Laboratories' Russian subsidiary and Novartis Pharma signed a deal for the distribution of anti-diabetes products.

Read more
reddy: DRL acquires injectable portfolio from US-based Eton Pharma for $50 million -

(economictimes.com)

reddy: DRL acquires injectable portfolio from US-based Eton Pharma for $50 million -

The portfolio includes the Biorphen (phenylephrine hydrocholoride) injection and Rezipres (ephedrine hydrochloride) injection NDAs (new drug application) with nine separate combinations of strengths and presentations and one first- to-file approved ANDA for Cysteine Hydrochloride for the US.

Read more

Never miss a headline about DRL

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages